PHASE II TRIAL OF PATUPILONE IN PATIENTS WITH BREAST CANCER BRAIN METASTASES

被引：0
|
作者：
Peereboom, D. M. [1 ]
Conlin, A. K. [2 ]
Seidman, A. D. [2 ]
Brewer, C. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1077 / 1077
页数：1
相关论文
共 50 条
  • [1] Phase II trial of patupilone in patients with breast cancer brain metastases
    Peereboom, David
    Brewer, Cathy
    Seidman, Andrew
    NEURO-ONCOLOGY, 2007, 9 (04) : 523 - 523
  • [2] Phase II trial of patupilone in patients with brain metastases from breast cancer
    Peereboom, David M.
    Murphy, Conleth
    Ahluwalia, Manmeet S.
    Conlin, Alison
    Eichler, April
    Van Poznak, Catherine
    Baar, Joseph
    Elson, Paul
    Seidman, Andrew D.
    NEURO-ONCOLOGY, 2014, 16 (04) : 579 - 583
  • [3] Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT)
    Conlin, A. K.
    D'Andrea, G.
    Hudis, C. A.
    Robson, M. E.
    Drullinsky, P.
    Theodoulou, M.
    Lis, E.
    Kang, T. Y.
    Peereboom, D. M.
    Seidman, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
    Jose Pablo Leone
    Kyrre E. Emblem
    Michelle Weitz
    Rebecca S. Gelman
    Bryan P. Schneider
    Rachel A. Freedman
    Jerry Younger
    Marco C. Pinho
    A. Gregory Sorensen
    Elizabeth R. Gerstner
    Gordon Harris
    Ian E. Krop
    Daniel Morganstern
    Jessica Sohl
    Jiani Hu
    Elizabeth Kasparian
    Eric P. Winer
    Nancy U. Lin
    Breast Cancer Research, 22
  • [5] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
    Leone, Jose Pablo
    Emblem, Kyrre E.
    Weitz, Michelle
    Gelman, Rebecca S.
    Schneider, Bryan P.
    Freedman, Rachel A.
    Younger, Jerry
    Pinho, Marco C.
    Sorensen, A. Gregory
    Gerstner, Elizabeth R.
    Harris, Gordon
    Krop, Ian E.
    Morganstern, Daniel
    Sohl, Jessica
    Hu, Jiani
    Kasparian, Elizabeth
    Winer, Eric P.
    Lin, Nancy U.
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [6] Phase II trial of lapatinib for brain metastases in patients with HER2+breast cancer.
    Lin, N. U.
    Carey, L. A.
    Liu, M. C.
    Younger, J.
    Come, S. E.
    Bullitt, E.
    Van den Abbeele, A. D.
    Li, X.
    Hochberg, F. H.
    Winer, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 3S - 3S
  • [7] Phase II trial of pembrolizumab in patients with brain metastases
    Brastianos, Priscilla Kaliopi
    Kim, Albert Eusik
    Giobbie-Hurder, Anita
    Lee, Eudocia Quant
    Lin, Nancy U.
    Overmoyer, Beth
    Wen, Patrick Y.
    Nayak, Lakshmi
    Cohen, Justine Vanessa
    Dietrich, Jorg
    Heist, Rebecca Suk
    Krop, Ian E.
    Lawrence, Donald P.
    Mayer, Erica L.
    Winer, Eric P.
    Shih, Helen Alice
    Oh, Kevin S.
    Cahill, Daniel P.
    Gerstner, Elizabeth R.
    Sullivan, Ryan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).
    Lin, Nancy U.
    Gelman, Rebecca Sue
    Younger, W. Jerry
    Sohl, Jessica
    Freedman, Rachel A.
    Sorensen, A. Gregory
    Bullitt, Elizabeth
    Harris, Gordon J.
    Morganstern, Daniel
    Schneider, Bryan P.
    Krop, Ian E.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer
    Hussain, A.
    DiPaola, R. S.
    Baron, A. D.
    Higano, C. S.
    Tchekmedyian, N. S.
    Johri, A. R.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 492 - 497
  • [10] Safety and efficacy of patupilone in patients with advanced breast cancer: a phase IIa trial.
    Toppnieyer, D. L.
    Mackey, J.
    Sessa, C.
    Johriar, A. R.
    Kaufman, P. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S73 - S74
12345